TGF-beta 3

TGF-beta 3

TGF-beta 3 詳細

Molecule Name
Transforming growth factor beta 3
分子の別称
TGFB3,ARVD,TGF-beta3
Drug Development Progress
治験薬の数3
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Transforming Growth Factor beta3,TGFB3,LAP,Prepro-Transforming Growth Factor Beta-3,TGF-Beta3,Transforming Growth Factor, Beta 3,ARVD1,LDS5,Arrhythmogenic Right Ventricular Dysplasia 1,RNHF,Transforming growth factor beta-3 proprotein,ARVD
バックグランド
Transforming growth factor beta 3 ( TGFB3) is also known as TGF-β3, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development. TGF-beta 3 is similar with TGF-beta 1 and ­-beta 2, act as cellular switches to regulate immune function, cell proliferation, and epithelial­-mesenchymal transition. TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3. Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal.

TGF-beta 3 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus Inc
Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
RG-6315RG-6315Phase 1 ClinicalGenentech Inc
Scleroderma, Systemic
詳細
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics Corp
Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
詳細